These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6304441)

  • 41. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Properties of opiate-receptor binding in rat brain.
    Pert CB; Snyder SH
    Proc Natl Acad Sci U S A; 1973 Aug; 70(8):2243-7. PubMed ID: 4525427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lithium chloride: protective and antisecretory properties in rats.
    Wong RK; Boedeker B; Hickey TM; Wilkinson DS; Johnson LF
    Gastroenterology; 1984 Aug; 87(2):362-71. PubMed ID: 6329891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of two [3H]ketanserin recognition sites in rat striatum.
    Roth BL; McLean S; Zhu XZ; Chuang DM
    J Neurochem; 1987 Dec; 49(6):1833-8. PubMed ID: 2960784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of monovalent cations on the binding of a charged and an uncharged ('carbo'-)muscarinic antagonist to muscarinic receptors.
    Hou X; Wehrle J; Menge W; Ciccarelli E; Wess J; Mutschler E; Lambrecht G; Timmerman H; Waelbroeck M
    Br J Pharmacol; 1996 Mar; 117(5):955-61. PubMed ID: 8851517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
    De Souza EB; Kuyatt BL
    Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants.
    Kendall DA; Nahorski SR
    J Pharmacol Exp Ther; 1985 May; 233(2):473-9. PubMed ID: 2987487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.
    Leysen JE; Awouters F; Kennis L; Laduron PM; Vandenberk J; Janssen PA
    Life Sci; 1981 Mar; 28(9):1015-22. PubMed ID: 6261070
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibitory effect of lithium on neuroleptic and serotonin receptors in rat brain.
    Tanimoto K; Maeda K; Terada T
    Brain Res; 1983 Apr; 265(1):148-51. PubMed ID: 6850317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of lithium on the renal excretory function and Na, K-ATPase activity in rats].
    Vasil'eva VF; Gusev GP; Krestinskaia TV
    Fiziol Zh SSSR Im I M Sechenova; 1981 Dec; 67(12):1866-72. PubMed ID: 6277703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lithium-induced decrease of brain inositol and increase of brain inositol-1-phosphate is transient.
    Hirvonen MR; Savolainen K
    Neurochem Res; 1991 Aug; 16(8):905-11. PubMed ID: 1664916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Modification, by lithium, of catalepsy induced by central cholinergic stimulants and morphine-like drugs].
    Scotto di Tella AM
    C R Seances Soc Biol Fil; 1981; 175(3):357-63. PubMed ID: 6268258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [3H]ketanserin (serotonin type 2) binding increases in rat cortex following basal forebrain lesions with ibotenic acid.
    Wenk GL; Engisch KL
    J Neurochem; 1986 Sep; 47(3):845-50. PubMed ID: 2942641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.
    Hoyer D; Pazos A; Probst A; Palacios JM
    Brain Res; 1986 Jun; 376(1):97-107. PubMed ID: 2941113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term lithium treatment causes serotonin receptor down-regulation via serotonergic presynapses in rat brain.
    Hotta I; Yamawaki S; Segawa T
    Neuropsychobiology; 1986; 16(1):19-26. PubMed ID: 3494960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reconstitution of solubilized serotonin-S2 receptors into phospholipid vesicles.
    Wouters W; van Hertrooy JJ; Krekels MD; Laduron PM
    J Recept Res; 1986; 6(3-4):271-82. PubMed ID: 3806498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lithium administration and urinary electrolyte excretion in the rat.
    Thompson L; Morgan T; Carney S
    Miner Electrolyte Metab; 1984; 10(2):122-6. PubMed ID: 6321937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lithium: effects on serotonin receptors in rat brain.
    Treiser S; Kellar KJ
    Eur J Pharmacol; 1980 Jun; 64(2-3):183-5. PubMed ID: 7398763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization and localization of serotonin receptors in human brain postmortem.
    Biegon A; Kargman S; Snyder L; McEwen BS
    Brain Res; 1986 Jan; 363(1):91-8. PubMed ID: 2936426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.